Nicotine metabolic profile in man: comparison of cigarette smoking and transdermal nicotine.
about
Beneficial effects of nicotine, cotinine and its metabolites as potential agents for Parkinson's diseaseThe ability of plasma cotinine to predict nicotine and carcinogen exposure is altered by differences in CYP2A6: the influence of genetics, race, and sexNicotine chemistry, metabolism, kinetics and biomarkersOverview of Cotinine Cutoff Values for Smoking Status ClassificationTrans-3'-hydroxycotinine: disposition kinetics, effects and plasma levels during cigarette smokingNovel Association of Genetic Markers Affecting CYP2A6 Activity and Lung Cancer RiskDifferent profiles of carcinogen exposure in Chinese compared with US cigarette smokersMethodologies for the quantitative estimation of toxicant dose to cigarette smokers using physical, chemical and bioanalytical dataQuantification of nicotine, cotinine, trans-3'-hydroxycotinine, nornicotine and norcotinine in human meconium by liquid chromatography/tandem mass spectrometry.Nicotine metabolism in African Americans and European Americans: variation in glucuronidation by ethnicity and UGT2B10 haplotype.Design, baseline characteristics, and retention of African American light smokers into a randomized trial involving biological data.Estimation of nicotine dose after low-level exposure using plasma and urine nicotine metabolites.UGT2B10 genotype influences nicotine glucuronidation, oxidation, and consumption.Enzyme-linked immunosorbent assay of nicotine metabolitesAssociation of CHRNA5-A3-B4 SNP rs2036527 with smoking cessation therapy response in African-American smokersNicotine metabolism in pregnant and nonpregnant rabbitsUtility and cutoff value of hair nicotine as a biomarker of long-term tobacco smoke exposure, compared to salivary cotinineNornicotine nitrosation in saliva and its relation to endogenous synthesis of N'-nitrosonornicotine in humans.In vivo versus in vitro airway surface liquid nicotine levels following cigarette smoke exposureGlucuronidation genotypes and nicotine metabolic phenotypes: importance of functional UGT2B10 and UGT2B17 polymorphismsUrine menthol as a biomarker of mentholated cigarette smoking.Biomarkers of Exposure to New and Emerging Tobacco and Nicotine Delivery Products.Variation in trans-3'-hydroxycotinine glucuronidation does not alter the nicotine metabolite ratio or nicotine intake.UGT1A and UGT2B genetic variation alters nicotine and nitrosamine glucuronidation in european and african american smokers.Nicotine exposure and metabolizer phenotypes from analysis of urinary nicotine and its 15 metabolites by LC-MS.Racial differences in the relationship between number of cigarettes smoked and nicotine and carcinogen exposure.A comparison of nicotine dose estimates in smokers between filter analysis, salivary cotinine, and urinary excretion of nicotine metabolites.Genetic influences on individual differences in nicotine glucuronidationCigarette nicotine yields and nicotine intake among Japanese male workers.Glucuronidation of trans-3'-hydroxycotinine by UGT2B17 and UGT2B10.Bupropion for smoking cessation in African American light smokers: a randomized controlled trial.2'-Hydroxylation of nicotine by cytochrome P450 2A6 and human liver microsomes: formation of a lung carcinogen precursor.Menthol smoking in relation to time to first cigarette and cotinine: results from a community-based study.Urinary nicotine metabolite excretion and lung cancer risk in a female cohort.Effects upon in-vivo nicotine metabolism reveal functional variation in FMO3 associated with cigarette consumptionA comparison of nicotine biomarkers and smoking patterns in daily and nondaily smokers.Modelling foetal exposure to maternal smoking using hepatoblasts from pluripotent stem cells.A prospectively measured serum biomarker for a tobacco-specific carcinogen and lung cancer in smokers.Alaska Native smokers and smokeless tobacco users with slower CYP2A6 activity have lower tobacco consumption, lower tobacco-specific nitrosamine exposure and lower tobacco-specific nitrosamine bioactivation.Using Monte Carlo simulation to assess variability and uncertainty of tobacco consumption in a city by sewage epidemiology.
P2860
Q21131066-AC778ED0-E495-4AA1-9DEE-B87F5B0C1395Q24595571-02640347-B780-4BAA-9B2A-4280B85B387BQ24632647-DA668A23-DFA6-4CB4-AE27-D462144378F9Q28079007-3252D6C7-F7FE-4F13-B3F4-2159CFF74E08Q28346917-CDD2585C-5FDB-4F39-B3EB-E3BC2BDBFD44Q28390824-30012059-5427-4656-A361-4ED274F99AB9Q28396981-20C3FF4C-AD97-449C-8517-2087A387E82EQ30641986-B14047CB-D4DC-4309-8046-4106D5BAFB7CQ33439159-7386FC38-972D-4F91-A202-BCDE596D5290Q33574895-A6AFFE6C-9D7B-440F-B5B2-C676C7686807Q33803436-CB38D9B1-1305-4367-B294-19901F8716B9Q33839242-5EFDD970-7AB1-4BD5-BAD1-457DACD9AA61Q33903103-0F92A7A1-1BFB-4403-93BC-1E96BBB73577Q33918098-ACD97195-FCA6-4F56-9F7B-C6F815EFE7A6Q33953232-75E42AC5-9089-468A-8126-76349EB59442Q34071786-B76CC2F9-6D56-4C44-A4AC-FD62E0DC2151Q34086169-77D203B6-0AB6-450D-B295-C17737FE0ADDQ34296046-04FD7AA2-598A-467F-A670-034CCCD747D6Q34365373-88B0772A-7400-4130-A59C-13E91A344407Q34390412-2B723FDC-A01E-4CC5-BA1F-B8E66324911DQ34422437-085D13CF-A59A-4AFF-A19B-A5B9B6ABE812Q34556938-3684D891-EFC6-4F93-9A0C-D0810D8A4F59Q34926339-8C447141-3E16-4806-98AD-AC6E7390683FQ34964392-7D66CD3E-B53B-45A5-82EA-BCD3423EE4D2Q35099123-464F1E81-023B-48EE-BF1B-83DEA3FC9175Q35200071-F989A6D3-190E-4D23-809D-F2808DEC1F7DQ35230191-2CAE43AB-B172-4436-AC44-57EF8C8974E3Q35453743-6E30E363-FA8B-4EF3-A381-BFA4FD9F7DB7Q35538304-241577F9-D75E-4A6B-8257-AA292811B97EQ35745357-AEAC4253-4482-4B44-BB5A-CE7E3C36C558Q35769015-17C835C1-E33E-4A95-80F0-7707E0DABBC9Q35815009-2882C223-798F-49ED-AEEC-85FCD3098E6CQ36021380-208F713E-28E5-4F01-A859-AAFDDB6B4924Q36081209-CB71088D-54E8-422E-A15E-C4130433419EQ36093134-59EA1E9F-E217-495C-8710-3B7344990DDEQ36207852-7376F5A4-7331-4BC6-9527-79BADB7A17DCQ36373223-ED9A0E1F-0F18-4F7C-A0F9-C220364C6DF9Q36441730-5EC15FCB-5564-4C84-86F7-0CB82330A401Q36499756-D32335C2-FAA6-4752-9245-3AE6CBF1DF94Q36602905-7D17EF05-8D88-4699-B343-AAAEF8498338
P2860
Nicotine metabolic profile in man: comparison of cigarette smoking and transdermal nicotine.
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年学术文章
@wuu
1994年学术文章
@zh-cn
1994年学术文章
@zh-hans
1994年学术文章
@zh-my
1994年学术文章
@zh-sg
1994年學術文章
@yue
1994年學術文章
@zh
1994年學術文章
@zh-hant
name
Nicotine metabolic profile in ...... king and transdermal nicotine.
@en
Nicotine metabolic profile in ...... king and transdermal nicotine.
@nl
type
label
Nicotine metabolic profile in ...... king and transdermal nicotine.
@en
Nicotine metabolic profile in ...... king and transdermal nicotine.
@nl
prefLabel
Nicotine metabolic profile in ...... king and transdermal nicotine.
@en
Nicotine metabolic profile in ...... king and transdermal nicotine.
@nl
P2093
P1476
Nicotine metabolic profile in ...... king and transdermal nicotine.
@en
P2093
P304
P407
P577
1994-01-01T00:00:00Z